Communicating statin evidence to support shared decision-making.

Area of Science:

• Medical Ethics
• Clinical Decision-Making
• Evidence-Based Medicine

Background:

• Clinical medicine integrates ethical principles with scientific knowledge.
• Balancing beneficence (patient best interest) and autonomy (patient choice) is crucial.
• Clinical communication is complex due to evidence uncertainty and treatment risks/benefits.

Purpose of the Study:

• To highlight the neglect of patient-oriented issues in shared decision-making guidelines.
• To examine statin guidelines as a case study for shared decision-making.
• To advocate for patient-centered approaches in medical decision-making.

Main Methods:

• Review of evidence-based clinical guidelines, focusing on statin use for cardiovascular event prevention.
• Analysis of meta-analyses of randomized trials on statin efficacy.
• Conceptual analysis of shared decision-making principles.

Main Results:

• Current guidelines recommend statins for 10-year cardiovascular risk as low as 7.5%, a shift from previous 20% benchmarks.
• Statins reduce cardiovascular event rates by approximately 25% (e.g., 7.5% to 5.6% risk).
• The justification for statin use depends on individual valuation of benefits versus harms and inconveniences.

Conclusions:

• Evidence-based guidelines often fail to prioritize individual patient values in shared decision-making.
• The decision regarding medication use, like statins, ultimately rests with the individual patient.
• Development of shared decision-making tools is needed to present evidence clearly and support patient autonomy.